DTwP-HepB-Hib vaccine
| Combination of | |
|---|---|
| DTP vaccine | Vaccine |
| Hepatitis B vaccine | Vaccine |
| Haemophilus vaccine | Vaccine |
| Clinical data | |
| Trade names | Quintavax, Pentavac, Pentacel, others |
| Routes of administration | Intramuscular injection |
| ATC code | |
| Identifiers | |
| CAS Number |
|
DTwP-HepB-Hib vaccine is a 5-in-1 combination vaccine with five individual vaccines conjugated into one.[1] It protects against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type B,[1] which is generally used in middle- and low-income countries, where polio vaccine is given separately.[2][3]
By 2013, pentavalent vaccines accounted for 100% of the DTP-containing vaccines procured by UNICEF, which supplies vaccines to a large proportion of the world's children.[4]
- ^ a b Cite error: The named reference
OVGwas invoked but never defined (see the help page). - ^ World Health Organization, World Health Organization Department of Immunization, Vaccines and Biologicals (2004). Immunization in Practice: A Practical Guide for Health Staff. World Health Organization. p. 20. ISBN 9789241546515. Retrieved 15 July 2018.
- ^ Malhame M, Baker E, Gandhi G, Jones A, Kalpaxis P, Iqbal R, et al. (August 2019). "Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market". Vaccine. 2 100033. doi:10.1016/j.jvacx.2019.100033. PMC 6668221. PMID 31384748.
- ^ "Diphtheria Tetanus and Pertussis Vaccine Supply Update" (PDF). UNICEF. October 2016. Archived from the original (PDF) on 29 June 2018. Retrieved 28 June 2018.